Semaglutide, marketed under brand names including Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management and chronic weight management
Other findings include: About eight in ten (82%) adults say they have heard at least a little about these drugs, including about three in ten (32%) who say they have heard a lot about them
Youre cutting back on treatment time, waiting time, travel time and, more importantly, you have a group of doctors, rather than a doctor, who are talking about your care, said Hematologist and Oncologist Dr
It can worsen GI side effects, particularly nausea and bloating
Weight gain can be one of the most frustrating aspects of hypothyroidism because it often feels like the body is working against you